Not Yet Recruiting
Clinical Study of LV009 Injection in the Treatment of Recurrent/Refractory CD19 Positive Blood Tumors
NCT07330895
- Conditions
- CD19+ Relapse/Refractory B-ALL, Disease Attributes, Pathologic Processes, +2 more
- Locations
-
Not specified